Agios Pharmaceuticals
AGIO
#4872
Rank
HK$15.92 B
Marketcap
HK$267.76
Share price
3.26%
Change (1 day)
-3.91%
Change (1 year)

Agios Pharmaceuticals (AGIO) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : HK$0.59 Billion

According to Agios Pharmaceuticals 's latest financial reports the company's total liabilities are HK$0.59 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Agios Pharmaceuticals - Total liabilities on balance sheet (from 2012 to 2026)

Total liabilities by year

Year Total liabilities Change
2025-12-31HK$0.81 B-14.64%
2024-12-31HK$0.94 B-3.64%
2023-12-31HK$0.98 B-8.6%
2022-12-31HK$1.07 B-5.2%
2021-12-31HK$1.13 B-67.67%
2020-12-31HK$3.51 B80.39%
2019-12-31HK$1.94 B45.59%
2018-12-31HK$1.33 B-28.29%
2017-12-31HK$1.86 B-7.6%
2016-12-31HK$2.02 B247.76%
2015-12-31HK$0.58 B10.89%
2014-12-31HK$0.52 B-3.11%
2013-12-31HK$0.54 B-25.09%
2012-12-31HK$0.72 B-29.25%
2011-12-31HK$1.02 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
HK$918.77 B 154,383.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$669.23 B 112,424.55%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$471.77 B 79,223.49%๐Ÿ‡ฌ๐Ÿ‡ง UK
Xencor
XNCR
HK$1.88 B 216.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
HK$5.15 B 767.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
HK$18.64 B 3,035.30%๐Ÿ‡บ๐Ÿ‡ธ USA